Background: The primary goals of this interdisciplinary consensus statement are to define
the eligibility criteria for management of recurrent and persistent cervical nodal disease in …

Abstract This American Head and Neck Society (AHNS) consensus statement focuses on
the detection and management of recurrent thyroid cancer. This document describes the …

Occasionally in medicine a clinical situation that ap-pears simple on the surface is, in reality,
much more difficult and complex. Such is the case with the common occurrence (estimated …

Background Well‐differentiated thyroid cancer (WDTC) recurs in up to 30% of patients.
Guidelines from the American Thyroid Association (ATA) and the National Comprehensive …

Background: The most frequent site of recurrence of differentiated thyroid cancer (DTC) is
cervical lymph nodes (LNs), which often necessitates repeated surgical interventions and …

Background: Active surveillance has been proposed as an appropriate management
strategy for low-risk differentiated thyroid cancer (DTC), due to the typically favorable …

The incidence of thyroid cancer in the United States has been increasing over the past
several decades. Some attribute this increase to improved detection rates of small papillary …

Context Differentiated thyroid cancer (DTC) has an excellent prognosis, but up to 20% of
patients with DTC have disease events after initial treatment, indistinctly defined as …

Background: The risk of recurrence in patients with differentiated thyroid cancer (DTC) can
be estimated based on their response to initial therapy. The aim of this study was to evaluate …

Introduction: Differentiated thyroid cancer (DTC), which includes papillary and follicular, is
the most common type of thyroid cancer and the incidence is rising. Survival rates of DTC …